drugset / Trial / NCT02301286
A Trial of Aspirin on Recurrence and Survival in Colon Cancer Patients
Phase 3
Active not recruiting
770 enrolled
Leiden University
Dutch Colorectal Cancer Group · collabFonds NutsOhra · collabInnovatiefonds Zorgverzekeraars · collabStichting Geriatrische Oncologie Nederland (GeriOnNe) · collabStichting voor Patienten met Kanker aan het Spijsverteringskanaal (SPKS) · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine whether acetylsalicylic acidis effective on the recurrence and survival of colon cancer patients.
Timeline
- Start
- 2015-01
- Primary completion
- 2027-12
- Completion
- 2027-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aspirin | Small molecule | 80 mg | Oral |